Perbedaan Budi Starch Sweetener Tbk dan Charlie Hospital Semarang Tbk.: Budi Starch Sweetener Tbk diperdagangkan di Rp220 (kapitalisasi pasar 980,78 M, volume 24 jam 483 rb), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp310 (kapitalisasi pasar 816,2 M, volume 24 jam 25,44 jt). Perbedaan utamanya: Budi Starch Sweetener Tbk lebih besar dari sisi kapitalisasi pasar, dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (25,44 jt vs 483 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BUDI | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 980,78 M | 816,2 M |
Volume | 483 rb | 25,44 jt |
Lot | 4,83 rb | 254,36 rb |
Perputaran | 107,13 jt | 7,84 M |
Harga Rata-rata | 221,8 | 308,07 |
Nilai Transaksi | 107,13 jt | 7,84 M |
Harga Ekuilibrium Indikatif | 224 | 310 |
Volume Ekuilibrium Indikatif | 12 | 100 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Selengkapnya di halaman BUDI →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →